IP Library › Granted Patent US 12,281,331
Granted Patent B2
US 12,281,331 · App. 18/507,966 · Granted Apr 22, 2025

Separation, dissociation and/or disaggregation of cells using shockwaves or mechanical impacts

Inventors: John Chi (Pasadena, CA); Ben-Chen Chi (Pasadena, CA)
Assignee: Synova Life Sciences, Inc.
C12N5/0667C12M45/02C12N2509/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,281,331
App. No.
18/507,966
Granted
Apr 22, 2025
Kind
B2
Abstract

Methods provided by the present disclosure utilize extracorporeal shockwaves, mechanical impacts and/or principles of lithotripsy to break up a tissue sample into smaller fragments—clusters of cells and/or single cells—after which a desired cellular fraction can be isolated from the sample. Devices provided by the present disclosure deploy focused and/or directed shockwaves, and/or focused and directed mechanical impacts, to break apart a tissue sample. The devices maintain the sample in a sterile, closed environment during exposure to the shockwaves or mechanical impacts. Therefore, the shockwaves and/or mechanical impacts are generated outside of a closed device and are transmitted through one or more walls of the device into its interior, where the sample is located.

Claims (28)

1. A method of isolating a stromal vascular fraction from tissue, comprising:

placing a tissue sample into a processing container of a tissue processing device;

subjecting the tissue sample to force from mechanical impacts to break down the tissue; and

separating the stromal vascular fraction from the tissue;

wherein:

the mechanical impacts are generated by an impact arm that makes physical contact with the processing container; and

the impact arm does not physically contact the tissue.

2. The method of claim 1 , wherein the processing device comprises:

a platform to which the processing container is secured; and

a first motor that drives up and down articulation of the impact arm.

3. The method of claim 1 , wherein the processing container is a cartridge.

4. The method of claim 1 , wherein the force from the mechanical impacts is delivered to the tissue through a wall of the processing container.

5. The method of claim 1 , wherein the separating comprises allowing the tissue to separate from an aqueous layer, the aqueous layer comprising the stromal vascular fraction.

6. The method of claim 1 , wherein the stromal vascular fraction is isolated from the tissue in 30 minutes or less.

7. The method of claim 1 , wherein the stromal vascular fraction comprises stem cells, growth factors and progenitor cells.

8. The method of claim 1 , wherein the tissue is selected from adipose tissue, brain tissue, pharyngeal tissue, laryngeal tissue, heart tissue, arterial tissue, muscle tissue, liver tissue, gall bladder tissue, kidney tissue, small intestinal tissue, large intestinal tissue, lymph node tissue, lung tissue, spleen tissue, bone marrow tissue, stomach tissue, venous tissue, pancreatic tissue, urinary bladder tissue, bone, teeth, dentin tissue, gum tissue, skin tissue, pineal gland tissue, pituitary gland tissue, thyroid gland tissue, adrenal gland tissue, pancreatic tissue, ovarian tissue and testicular tissue.

9. The method of claim 2 , wherein the first motor is a variable speed motor.

10. The method of claim 9 , wherein the first motor drives the impact arm such that the impact arm articulates up and down at a rate of up to 30,000 rpm, making physical contact with the processing container.

11. The method of claim 10 , wherein the first motor drives the up and down articulation of the impact arm at a rate of up to 5,000 rpm.

12. The method of claim 10 , wherein the articulation of the impact arm generates mechanical impacts that are imparted to an outside surface of the processing container that break down the tissue and separate the stromal vascular fraction from the adipose tissue.

13. The method of claim 12 , wherein the first motor controls the speed at which the impact arm makes contact with the processing container.

14. The method of claim 13 , wherein the first motor is controlled by a microprocessor.

15. The method of claim 1 , wherein the processing container is a cartridge.

16. The method of claim 1 , wherein the processing container does not contain enzymes other than those in the tissue.

17. The method of claim 1 , wherein the impacts do not cause mixing of the stromal vascular fraction and the remaining tissue.

18. The method of claim 2 , wherein the processing device comprises a second motor that controls movement of the platform.

19. The method of claim 18 , wherein the second motor controls vertical movement of the platform.

20. The method of claim 4 , wherein the mechanical impacts are imparted to an outside surface of the processing container.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2024
From: CHI, JOHN; RAVEN, RAYMOND; RICHMAN, MARK; CHI, BEN-CHEN
To: SYNOVA LIFE SCIENCES, INC.
Reel/Frame 066440/0213 →
Continuity (3)
Continuation 16085200
Provisional Application 62309774 · Mar 17, 2016
Related Publication 20240076622A1 · Mar 7, 2024
References Cited (75)
US 5728130A · Ishikawa et al. · 1998 [cited by applicant]
US 6890728B2 · Doleck et al. · 2005 [cited by applicant]
US 7018354B2 · Tazi · 2006 [cited by applicant]
US 7077559B2 · Hlavinka et al. · 2006 [cited by applicant]
US 10329533B2 · Chi et al. · 2019 [cited by applicant]
US 10668105B2 · Harman et al. · 2020 [cited by applicant]
US 11866732B2 · Chi et al. · 2024 [cited by applicant]
US 20050025755A1 · Hedrick et al. · 2005 [cited by applicant]
US 20050095228A1 · Fraser et al. · 2005 [cited by applicant]
US 20050132775A1 · Laugharn et al. · 2005 [cited by applicant]
US 20050256077A1 · Henning · 2005 [cited by applicant]
US 20060051865A1 · Higgins et al. · 2006 [cited by applicant]
US 20080009885A1 · Del Giglio · 2008 [cited by applicant]
US 20080014181A1 · Ariff et al. · 2008 [cited by applicant]
US 20080186802A1 · Bungay et al. · 2008 [cited by applicant]
US 20090169642A1 · Fradette et al. · 2009 [cited by applicant]
US 20090304644A1 · Hedrick et al. · 2009 [cited by applicant]
US 20100112696A1 · Min · 2010 [cited by applicant]
US 20100152880A1 · Boyden et al. · 2010 [cited by applicant]
US 20110034832A1 · Cioanta et al. · 2011 [cited by applicant]
US 20120100611A1 · Kensy et al. · 2012 [cited by applicant]
US 20120164113A1 · Victor et al. · 2012 [cited by applicant]
US 20120195862A1 · Daley et al. · 2012 [cited by applicant]
US 20130034524A1 · Adha-Mohammadi · 2013 [cited by applicant]
US 20130344589A1 · Winkler et al. · 2013 [cited by applicant]
US 20140017783A1 · Gimble et al. · 2014 [cited by applicant]
US 20150093809A1 · Alt et al. · 2015 [cited by applicant]
US 20150218506A1 · Nash et al. · 2015 [cited by applicant]
US 20150231244A1 · Chi et al. · 2015 [cited by applicant]
US 20150353891A1 · Peterson et al. · 2015 [cited by applicant]
US 20160024450A1 · Quick et al. · 2016 [cited by applicant]
CN 2687654 · 2005 [cited by applicant]
CN 1630526 · 2005 [cited by applicant]
CN 1842589 · 2005 [cited by applicant]
CN 102311941 · 2012 [cited by applicant]
CN 102433299 · 2012 [cited by applicant]
CN 102458302 · 2012 [cited by applicant]
CN 103203043 · 2013 [cited by applicant]
CN 103263440 · 2013 [cited by applicant]
CN 203200258 · 2013 [cited by applicant]
CN 103402646 · 2013 [cited by applicant]
CN 103443272 · 2013 [cited by applicant]
CN 103484365 · 2014 [cited by applicant]
CN 103842496 · 2014 [cited by applicant]
CN 104704111 · 2015 [cited by applicant]
CN 204752692 · 2015 [cited by applicant]
CN 106834121 · 2017 [cited by applicant]
CO 08134632 · 2010 [cited by applicant]
DE 102015109148 · 2016 [cited by applicant]
JP S61230957 · 1986 [cited by applicant]
JP 2005218376 · 2005 [cited by applicant]
JP 2016028614 · 2016 [cited by applicant]
KR 102009000784 · 2009 [cited by applicant]
WO WO2007139551 · 2007 [cited by applicant]
WO WO2013086199 · 2013 [cited by applicant]
WO WO2014000031 · 2014 [cited by applicant]
WO WO2017161343 · 2017 [cited by applicant]
“Agitador vortex modelo Vortex MS3 Basic, marca IKA,” (with English translation) Zelian Equipamiento De Laboratorio, Date Last Modified Apr. 15, 2021, retrieved from https://www.zelian.com.ar/detalle.php?articulo=EQL-01… [cited by applicant]
Burden, “Guide to the Disruption of Biological Samples—2012,” Random Primers, No. 12, Jan. 2012, 25 pages. [cited by applicant]
Condé-Green et al., “Shift toward Mechanical Isolation of Adipose-derived Stromal Vascular Fraction: Review of Upcoming Techniques,” PRS Global Open, vol. 4, No. 9, Sep. 1, 2016, 9 pages. [cited by applicant]
Raposio et al., “A Novel and Effective Strategy for the Isolation of Adipose-Derived Stem Cells: Minimally Manipulated Adipose-Derived Stem Cells for More Rapid and Safe Stem Cell Therapy,” Plastic Reconstructive Surger… [cited by applicant]
Official Action for U.S. Appl. No. 14/626,634, dated Jul. 26, 2017, 7 pages. [cited by applicant]
Official Action for U.S. Appl. No. 14/626,634, dated Jan. 19, 2018, 7 pages. [cited by applicant]
Official Action for U.S. Appl. No. 14/626,634, dated Apr. 11, 2018, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 14/626,634, dated Feb. 8, 2019, 8 pages. [cited by applicant]
Supplemental Notice of Allowance for U.S. Appl. No. 14/626,634, dated Apr. 11, 2019, 2 pages. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Jul. 13, 2020, 8 pages. Restriction Requirement. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Jan. 12, 2021, 9 pages. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Jun. 23, 2021, 10 pages. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Dec. 22, 2022, 10 pages. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Jul. 13, 2022, 10 pages. [cited by applicant]
Official Action for U.S. Appl. No. 16/085,200, dated Feb. 24, 2023, 12 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/085,200, dated Oct. 31, 2023, 10 pages. [cited by applicant]
Goldberg, “Chapter 1: Mechanical/Physical Methods of Cell Disruption and Tissue Homogenization,” in Methods in Molecular Biology, 2D Page: Sample Preparation and Fractionation (ed. Posch), vol. 424, Jan. 1, 2008, pp. 3-… [cited by applicant]
Gray et al., “Development of a Novel Digestion Chamber for Human and Porcine Islet Isolation,” Transplantation Proceedings, vol. 36, No. 4, May 1, 2004, pp. 1135-1138. [cited by applicant]